No Need for Prophylactic Abdominal Ice Packing During Radioembolization
Letter to the Editor
First Online:
Received:
Accepted:
- 101 Downloads
Notes
Compliance with Ethical Standards
Conflict of interest
AJATB has no conflicts of interest. MEGHL has acted as a consultant for BTG, Sirtex, Mirada and Bayer Healthcare. University Medical Center Utrecht receives royalties from Quirem Medical B.V. (producer of 166Ho microspheres).
Ethical Approval
All procedures performed were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
Informed Consent
Need for informed consent in this retrospective study was waived by the institutional ethics committee.
References
- 1.Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, Benson A 3rd, Espat J, Bilbao JI, Sharma RA, Thomas JP, Coldwell D. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys. 2007;68(1):13–23. doi: 10.1016/j.ijrobp.2006.11.060.CrossRefPubMedGoogle Scholar
- 2.Braat AJAT, Smits MLJ, Braat MNGJA, van den Hoven AF, Prince JF, de Jong HWAM, van den Bosch MAAJ, Lam MGEH. Y hepatic radioembolization: an update on current practice and recent developments. J Nucl Med. 2015;56(7):1079–87. doi: 10.2967/jnumed.115.157446.CrossRefPubMedGoogle Scholar
- 3.Borggreve AS, Landman AJ, Vissers CM, De Jong CD, Lam MGEH, Monninkhof EM, Prince JF. Radioembolization: Is prophylactic embolization of hepaticoenteric arteries necessary? A systematic review. Cardiovasc Interv Radiol. 2016;39(5):696–704. doi: 10.1007/s00270-016-1310-9.CrossRefGoogle Scholar
- 4.Wang DS, Louie JD, Kothary N, Shah RP, Sze DY. Prophylactic topically applied ice to prevent cutaneous complications of nontarget chemoembolization and radioembolization. J Vasc Interv Radiol. 2013;24(4):596–600. doi: 10.1016/j.jvir.2012.12.020.CrossRefPubMedGoogle Scholar
- 5.Leong QM, Lai HK, Lo RG, Teo TK, Goh A, Chow PK. Radiation dermatitis following radioembolization for hepatocellular carcinoma: a case for prophylactic embolization of a patent falciform artery. J Vasc Interv Radiol. 2009;20(6):833–6. doi: 10.1016/j.jvir.2009.03.011.CrossRefPubMedGoogle Scholar
- 6.Sharma AK, Foster TH, Katz A, Lee DE, Waldman DL. Supraumbilical rash caused by nontarget radioembolization to the falciform artery. J Vasc Interv Radiol. 2014;25(3):483–4. doi: 10.1016/j.jvir.2013.07.029.CrossRefPubMedGoogle Scholar
- 7.Ahmadzadehfar H, Möhlenbruch M, Sabet A, Meyer C, Muckle M, Haslerud T, Wilhelm K, Schild HH, Biersack HJ, Ezziddin S. Is prophylactic embolization of the hepatic falciform artery needed before radioembolization in patients with 99 mTc-MAA accumulation in the anterior abdominal wall? Eur J Nucl Med Mol Imaging. 2011;38(8):1477–84. doi: 10.1007/s00259-011-1807-z.CrossRefPubMedGoogle Scholar
- 8.Burgmans MC, Too CW, Kao YH, Goh AS, Chow PK, Tan BS, Tay KH, Lo RH. Computed tomography hepatic arteriography has a hepatic falciform artery detection rate that is much higher than that of digital subtraction angiography and 99mTc-MAA SPECT/CT: implications for planning 90Y radioembolization? Eur J Radiol. 2012;81(12):3979–84. doi: 10.1016/j.ejrad.2012.08.007.CrossRefPubMedGoogle Scholar
- 9.Beylergila V, Sofocleousc CT, Carrasquillo JA. Extrahepatic visualization in the distribution of falciform artery in post-treatment Bremsstrahlung images after radioembolization with 90Y microspheres. Rev Esp Med Nucl Imagen Mol. 2014;33(3):178–9.Google Scholar
- 10.Bhalani SM, Lewandowski RJ. Radioembolization complicated by nontarget embolization to the falciform artery. Semin Interv Radiol. 2011;28(2):234–9. doi: 10.1055/s-0031-1280672.CrossRefGoogle Scholar
- 11.Kao YH, Tan AE, Khoo LS, Lo RH, Chow PK, Goh AS. Hepatic falciform ligament Tc-99m-macroaggregated albumin activity on SPECT/CT prior to yttrium-90 microsphere radioembolization: prophylactic measures to prevent non-target microsphere localization via patent hepatic falciform arteries. Ann Nucl Med. 2011;25(5):365–9. doi: 10.1007/s12149-010-0464-9.CrossRefPubMedGoogle Scholar
Copyright information
© Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2017